European Society of Cardiology
Skip navigation links
Home
About the ESC
Membership
Communities
Congresses
Education
Guidelines & Surveys
Journals
Initiatives
Welcome to the European Society of Cardiology. Our mission: to reduce the burden of cardiovascular disease in Europe
 

Epidemiology & prevention

Find resources from the ESC Congress 2009 about this topic

Quick Access

ESC congress reports

ESC webcasts

ESC slides resources

ESC video news

Reports

Webcasts

Slides

Videos

 List of slides presentations on this topic


PresentationSpeakerDateTopic
Cardiovascular risk reduction in childhood: empirical evidence.Erbs, Sandra (Leipzig)30 Aug 2009Epidemiology & prevention
Political strategies for cardiovascular health in children.Deanfield, John Eric (London)30 Aug 2009Epidemiology & prevention
Weight and waist: risk factors for cardiovascular disease.Van Gaal, Luc (Edegem-Antwerp)30 Aug 2009Epidemiology & prevention
Therapeutic options for obesity in cardiovascular disease.Finer, Nick (London)30 Aug 2009Epidemiology & prevention
Mercury rising: global warming, carbon and cardiovascular health.Faergeman, Ole (Aarhus C)30 Aug 2009Epidemiology & prevention
Cars, fumes and cardiovascular disease.Twickler, Marcel (Amsterdam)30 Aug 2009Epidemiology & prevention
Have we cracked the 'gender barrier' in symptom recognition?Fridlund, Bengt GA (Jonkoping)30 Aug 2009Epidemiology & prevention
Hormonal replacement: for whom, when and for how long?Stevenson, John C (London)30 Aug 2009Epidemiology & prevention
Statins for women?Grobbee, Diederick E (Utrecht)30 Aug 2009Epidemiology & prevention
Is elevated resting heart rate an independent predictor of cardiovascular disease? A report from the National FINRISK Study.Cooney, Marie Therese (Dublin)30 Aug 2009Epidemiology & prevention
Resting heart rate remains a risk factor for CardioVascular (CV) and non-CardioVascular (non-CV) mortality in healthy subjects after adjusting for inflammatory markers. The Copenhagen city heart study.Jensen, Magnus Thorsten (Copenhagen)30 Aug 2009Epidemiology & prevention
Increased exercise capacity is associated with lower mortality risk in men 70 years and older.Kokkinos, Peter (Washington)30 Aug 2009Epidemiology & prevention
Adipokines and coronary heart disease - results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.Karakas, Mahir (Ulm)30 Aug 2009Epidemiology & prevention
Respective contribution of carotid intima-media thickness and plaques to incident coronary heart disease in community-dwelling elderly. The three-city study.Plichart, Matthieu (Paris)30 Aug 2009Epidemiology & prevention
Uric acid: an underestimated cardiovascular risk factor.Levantesi, Giacomo (Vasto)30 Aug 2009Epidemiology & prevention
Randomised controlled trial of low dose aspirin in the prevention of cardiovascular events and death in subjects with asymptomatic atherosclerosis: Discussant.Patrono, Carlo (Rome)30 Aug 2009Epidemiology & prevention
Diabetic patients: more than just stents or grafts.Roffi, Marco (Geneva 14)30 Aug 2009Epidemiology & prevention
Usefulness of triglycerides-to-HDL ratio to predict the first coronary event in active male workers: a case-control study.Cordero, Alberto (Alicante)30 Aug 2009Epidemiology & prevention
Italian smoking regulation decreased hospital admissions for acute coronary events:effect modification by age and day of the week.Barone Adesi, Francesco (turin)30 Aug 2009Epidemiology & prevention
Hidden diabetes in coronary artery disease - how to detect and is it worth while?Standl, Eberhard (Munich)30 Aug 2009Epidemiology & prevention
Panel discussion.Standl, Eberhard (Munich)30 Aug 2009Epidemiology & prevention
What do the Guidelines say?Ryden, Lars (Stockholm)30 Aug 2009Epidemiology & prevention
The worldwide hazards of smoking and benefits of stopping.Peto, Richard (Oxford)30 Aug 2009Epidemiology & prevention
Systemic vascular dysfunction in children conceived by assisted reproductive technologies.Rimoldi, Stefano Flavio (Bern)30 Aug 2009Epidemiology & prevention
Impact of behavioural and biologic cardiovascular risk factors on the relationship between stature and all-cause mortality: 8-years follow-up study in a cohort of Chilean adults.Koch, Elard (Santiago)30 Aug 2009Epidemiology & prevention
A smoking ban in public places may reduce the incidence of acute coronary syndrome among non-smoking men.Gudnason, Thorarinn (Reykjavik)30 Aug 2009Epidemiology & prevention
The impact of achieving risk factor targets on CVD events in a community-based study.Zomer, Ella (Melbourne)30 Aug 2009Epidemiology & prevention
Underestimation of the importance of isolated systolic hypertension in older people.Emberson, Jonathan (Oxford)30 Aug 2009Epidemiology & prevention
Association between anthropometric obesity measures and coronary artery disease - a cross-sectional survey of 16,657 subjects from 444 Polish cities.Kaess, Bernhard (Regensburg)30 Aug 2009Epidemiology & prevention
Thirty novel biomarkers as predictors of clinically incident diabetes.Salomaa, Veikko (Helsinki)30 Aug 2009Epidemiology & prevention
A consultation-based method is equal to SCORE and an extensive laboratory-based method in predicting risk of future cardiovascular disease .Petersson, Ulla (Soderakra)30 Aug 2009Epidemiology & prevention
Cardiovascular risk prediction in an Australian population: the old versus the new Framingham equation.Zomer, Ella (Melbourne)30 Aug 2009Epidemiology & prevention
Identifying novel predictors of 30-day mortality for acute coronary syndromes: diagnosis differential and the Myocardial Ischaemia National Audit Project (MINAP).Metcalfe, Elizabeth (Leeds)30 Aug 2009Epidemiology & prevention
High-density lipoprotein: a fall from grace?Kastelein, John (Amsterdam)30 Aug 2009Epidemiology & prevention
Enlightenment from ILLUMINATE?Barter, Philip (Sydney)30 Aug 2009Epidemiology & prevention
Novel high-density lipoprotein raising strategies.Nicholls, Stephen (Cleveland)30 Aug 2009Epidemiology & prevention
Value of fibrates and niacin.Ruschitzka, Frank (Zurich)30 Aug 2009Epidemiology & prevention
Cardiovascular safety and antidiabetic drugs.Cleland, John (Kingston upon Hull)30 Aug 2009Epidemiology & prevention
Cancer and lipid lowering drugs.Borghi, Claudio (Bologna)30 Aug 2009Epidemiology & prevention
Heart failure events assessment in the Rosiglitazone Evaluation for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): Discussant.Dickstein, Kenneth (Stavanger)30 Aug 2009Epidemiology & prevention
Treating dyslipidemia. How aggressive should we be? - Case 1.Landmesser, Ulf (Zurich)30 Aug 2009Epidemiology & prevention
Treating dyslipidemia. How aggressive should we be? - Case 2.Deanfield, John Eric (London)30 Aug 2009Epidemiology & prevention
Total risk assessment: principles and practice.Taskinen, Marja-Riitta (Helsinki)31 Aug 2009Epidemiology & prevention
Boomerang effect: from low-density lipoprotein to high-density lipoprotein and back.Landmesser, Ulf (Zurich)31 Aug 2009Epidemiology & prevention
Modern diabetic management; it's not just glucose.Berne, Christian (Uppsala)31 Aug 2009Epidemiology & prevention
Can we change society?Tuomilehto, Jaakko (Helsinki)31 Aug 2009Epidemiology & prevention
EUROASPIRE III: Risk factor and therapeutic management in people at high risk of developing cardiovascular disease from 12 European countries.Kotseva, Kornelia (London)31 Aug 2009Epidemiology & prevention
High prevalence of dyslipidemia in 18,574 patients treated with statins in Europe and Canada: Results of the dyslipidemia international study.Gitt, Anselm Kai (Ludwigshafen Am Rhein)31 Aug 2009Epidemiology & prevention
Trends in acute coronary syndrome management and early mortality: Myocardial Ischaemia National Audit Project (MINAP) 2004 to 2007.Simms, Alexander (Leeds)31 Aug 2009Epidemiology & prevention
Persistence with beta-blockers in coronary heart disease patients in UK primary care.Kassianos, George (Wokingham)31 Aug 2009Epidemiology & prevention
Identification of patients with impaired outcome on ACE-inhibitor therapy.Brugts, Jasper (Rotterdam)31 Aug 2009Epidemiology & prevention
Impact of non steroidal anti-inflammatory drugs (NSAIDs) on CV outcomes in atherothrombotic patients: insights from the European REACH registry.Barthelemy, Olivier (Paris)31 Aug 2009Epidemiology & prevention
New scientific advances in epidemiology & public health.De Sutter, Johan H A J (Gent)31 Aug 2009Epidemiology & prevention
Lipid-lowering drugs.Amarenco, Pierre (Paris Cedex)31 Aug 2009Epidemiology & prevention
Risk of death differs according to type of oral glucose-lowering therapy in patients with diabetes and a previous myocardial infarction: a nationwide study.Schramm, Tina Ken (Copenhagen)31 Aug 2009Epidemiology & prevention
Do angiotensin-converting enzyme inhibitors and angiotensin receptor blockers prevent the incidence of diabetes? A meta-analysis of more than 100,000 patients.Al-Mallah, Mouaz (Canton)31 Aug 2009Epidemiology & prevention
Does more intensive control of glucose reduce cardiovascular events in type 2 diabetes? .Sheshasai, Sreenivasa (Cambridge)31 Aug 2009Epidemiology & prevention
Diabetes is the strongest independent predictor of mortality in acute cerebrovascular disease.Margato, Renato (Maia)31 Aug 2009Epidemiology & prevention
Effect of multifactorial comprehensive cardiac rehabilitation on risk factor control and mortality in type 2 diabetes - three years results of the randomized DANSUK study.Soja, Anne Merete (Copenhagen)31 Aug 2009Epidemiology & prevention
How to cool the burning plaque.Fuster, Valentin (New York)31 Aug 2009Epidemiology & prevention
Risk factors have no boundaries.Wood, David Allan (London)31 Aug 2009Epidemiology & prevention
The differences in cardiovascular risk factors and treatment goal achievement between the Asian and the European: results of the Lipid Treatment Assessment Project 2 (L-TAP 2).Chiang, Fu-Tien (Taipei)31 Aug 2009Epidemiology & prevention
Global alert and prevention of infectious heart diseases.Matsumori, Akira (Kyoto)31 Aug 2009Epidemiology & prevention
Characterisation and functional role of endothelial progenitor cells in the arterial wall.Dimmeler, Stefanie (Frankfurt)31 Aug 2009Epidemiology & prevention
Clinical impact of endothelial progenitor cells on atherosclerotic disease.Landmesser, Ulf (Zurich)31 Aug 2009Epidemiology & prevention
Role of endogenous cardiac progenitor cell for cardiac revascularisation.Linke, Axel HP (Leipzig)31 Aug 2009Epidemiology & prevention
Role of stem cells in plaque growth and destabilisation.Martin, John (London)31 Aug 2009Epidemiology & prevention
Improved exercise capacity has a beneficial effect in long term mortality risk of prediabetics.Pittaras, Andreas (Athens)31 Aug 2009Epidemiology & prevention
Impact of Poly Unsaturated Fatty Acids(PUFAs) on positive remodeling of coronary plaques, a study by 64 slice MDCT(MultiDetector Computed Tomography).Domei, Takenori (Kitakyusyu)31 Aug 2009Epidemiology & prevention
Adherence to the Mediterranean diet and risk of atrial fibrillation.Mattioli, Anna Vittoria (Modena)31 Aug 2009Epidemiology & prevention
Interrelationship of lifestyle characteristics with dietary habits and childhood obesity among Greek adolescents. Preliminary data from the 3L Study.Tsiachris, Dimitris (Athens)31 Aug 2009Epidemiology & prevention
Good cholesterol control in a large disease management initiative : lessons from the LIVE program.Ho, Kheng-Thye (Singapore)31 Aug 2009Epidemiology & prevention
Is there an obesity paradox after percutaneous coronary intervention (PCI) in the contemporary era? Findings from a large multicentre Australian coronary angioplasty registry.Lancefield, Terase (Heidelberg)31 Aug 2009Epidemiology & prevention
Obesity, metabolic health and incidence of peripheral vascular disease during 9-years follow-up of the D.E.S.I.R. cohort.Skilton, Michael (Melbourne)31 Aug 2009Epidemiology & prevention
Obesity paradox in type 2 DM of the PROactive study population: Weight reduction but not weight gain is associated with increased mortality in patients with type 2 DM and high cardiovascular risk .Doehner, Wolfram (Berlin)31 Aug 2009Epidemiology & prevention
Prevalence and trends of the metabolic syndrome in French adults: the MONA LISA study.Arveiler, Dominique (Strasbourg Cedex)31 Aug 2009Epidemiology & prevention
Obesity is associated with better prognosis after implantation drug-eluting stents: the paradox of obesity .Santos, Nuno (Funchal)31 Aug 2009Epidemiology & prevention
Obesity, Waist Circumference and Metabolic Syndrome in the Portuguese Population. Insights of the VALSIM study.Fiuza, Maria Manuela (Lisbon)31 Aug 2009Epidemiology & prevention
Barriers to implementation.Graham, Ian (Dublin)31 Aug 2009Epidemiology & prevention
Factors influencing physician and patient behaviour.Albus, Christian (Cologne (Koeln))31 Aug 2009Epidemiology & prevention
A national plan for cardiovascular disease prevention.Erol, Cetin (Ankara)31 Aug 2009Epidemiology & prevention
Effect of rosiglitazone on coronary events in the RECORD study.McMurray, John (Glasgow)31 Aug 2009Epidemiology & prevention
Effect of rosiglitazone on coronary events in the RECORD study: Discussant.Charbonnel, Bernard (Nantes)31 Aug 2009Epidemiology & prevention
Randomized evidence on Rosuvastatin for primary prevention in individuals 70 years of age or older. JUPITER.Glynn, Robert (Boston)31 Aug 2009Epidemiology & prevention
Nonfasting cholesterol and triglycerides, myocardial infarction, and early death. Copenhagen City Heart: Discussant.Fuster, Valentin (New York)31 Aug 2009Epidemiology & prevention
New insights from the cardiogenics.Cambien, Francois (Paris)31 Aug 2009Epidemiology & prevention
Genome scanning identifies genes for blood pressure.Caulfield, Mark (London)31 Aug 2009Epidemiology & prevention
Olive oil, berries and chocolate.De Lorgeril, Michel (La Tronche)31 Aug 2009Epidemiology & prevention
Hop, skip or jump.Doherty, Patrick (York)31 Aug 2009Epidemiology & prevention
Too much of a good thing is ...Sharma, Sanjay (London)31 Aug 2009Epidemiology & prevention
Cardiovascular disease prevention in Europe - challenges and possible solutions.Ryden, Lars (Stockholm)31 Aug 2009Epidemiology & prevention
Variable response to antiplatelet drugs in diabetes.Angiolillo, Dominick Joseph (Jacksonville)31 Aug 2009Epidemiology & prevention
Advances in the prevention of atherothrombosis in diabetes.Verheugt, Freek (Amsterdam)31 Aug 2009Epidemiology & prevention
Why do we face the pandemic of low high-density lipoprotein cholesterol and coronary heart disease?Taskinen, Marja-Riitta (Helsinki)31 Aug 2009Epidemiology & prevention
High-density lipoprotein and reverse cholesterol transport.Calandra, Sebastiano (Modena)31 Aug 2009Epidemiology & prevention
Novel strategies for raising high-density lipoprotein cholesterol.Kastelein, John (Amsterdam)31 Aug 2009Epidemiology & prevention
Glucose; how low should you go.Tschoepe, Diethelm (Bad Oeynhausen)01 Sep 2009Epidemiology & prevention
Monitoring diabetics.Del Prato, Stefano (Pisa)01 Sep 2009Epidemiology & prevention
Lifestyle is the answer.Tuomilehto, Jaakko (Helsinki)01 Sep 2009Epidemiology & prevention
Generalized vascular damage and impaired endogenous regenerative capacity in children with obesity.Erbs, Sandra (Leipzig)01 Sep 2009Epidemiology & prevention
Legumes and glycemic control: A meta-analysis of randomized controlled trials.Kendall, Cyril William Charles (Toronto)01 Sep 2009Epidemiology & prevention
Impact of smoking prohibition in bars, restaurants and discotheques on employees endothelial function: the dilater study.Bura, Alessandra (Toulouse)01 Sep 2009Epidemiology & prevention
Trajectories of entering the metabolic syndrome: the Framingham heart study.Franco Duran, Oscar (Coventry)01 Sep 2009Epidemiology & prevention
Folic acid, homocysteine and risk of coronary heart disease and stroke: meta-analysis of 8 trials involving 37,500 participants.Clarke, Robert (Oxford)01 Sep 2009Epidemiology & prevention
Alcohol, beer, wine, spirits, drinking pattern and obesity.Bobak, Martin (London)01 Sep 2009Epidemiology & prevention
Impact of smoking on erectile function and arterial stiffness in middle-aged smokers without other major cardiovascular risk factors.Ioakeimidis, Nikolaos (Athens)01 Sep 2009Epidemiology & prevention
Lifestyle and cardiovascular risk factors in 1123 Families: The PEP family heart study.Haas, Gerda-Maria (Muenchen)01 Sep 2009Epidemiology & prevention
Long-term, moderate coffee consumption is associated with lower prevalence of diabetes mellitus among elderly non-tea drinkers from the Mediterranean Islands (MEDIS Study).Panagiotakos, Demosthenes B (Athens)01 Sep 2009Epidemiology & prevention
Trends in plasma lipids, lipoproteins and dyslipidemias in French adults, 1996-2007.Ferrieres, Jean (Toulouse)01 Sep 2009Epidemiology & prevention
Four-year treatment practice with extended-release niacin in Germany: adherence, treatment gaps and daily maintenance dose.Krobot, Karl Josef (Haar)01 Sep 2009Epidemiology & prevention
Effect of familial combined hyperlipidemia on arterial structure and function: a meta-analysis of case-control studies.Masoura, Konstantina (Athens)01 Sep 2009Epidemiology & prevention
Predominant types of dyslipidemia in patients with coronary heart disease treated with statins in Europe and Canada: data from the dyslipidemia international study.Gitt, Anselm Kai (Ludwigshafen Am Rhein)01 Sep 2009Epidemiology & prevention
Effect of statins on ventricular arrhythmic events: a collaborative meta-analysis of randomised controlled trials.Rahimi, Kazem (Oxford)01 Sep 2009Epidemiology & prevention
Stroke prevention in atrial fibrillation: who should be on more than aspirin?Mant, Jonathan (Cambridge)01 Sep 2009Epidemiology & prevention
What's the quality of cardiovascular care in European primary care?Ludt, Sabine (Heidelberg)01 Sep 2009Epidemiology & prevention
Abdominal aorta aneurysm: how to assess long-term prognosis and improve outcome?Poldermans, Don (Rotterdam)01 Sep 2009Epidemiology & prevention
Subendothelial lipoprotein retention - a novel target to prevent atherosclerosis.Boren, Jan (Goteborg)01 Sep 2009Epidemiology & prevention
Risk stratification and coronary heart disease.Silber, Sigmund (Muenchen)01 Sep 2009Epidemiology & prevention
Acquired immune deficiency syndrome in the heart of Africa.Mayosi, Bongani Mawethu (Cape Town)01 Sep 2009Epidemiology & prevention
Hypertension: meeting the need in Africa.Lemogoum, Daniel (Brussels)01 Sep 2009Epidemiology & prevention
Advances in the medical and surgical treatment of endomyocardial fibrosis.Mocumbi, Ana Olga (Maputo)01 Sep 2009Epidemiology & prevention
Valve disease - what are the priorities in Africa?Antunes, Manuel J (Coimbra)01 Sep 2009Epidemiology & prevention
The role of Pan African Society of Cardiology.Amoah, Albert George Baidoe (Accra.)01 Sep 2009Epidemiology & prevention
Outcomes of elderly patients with non-ST-elevation acute coronary syndromes according to treatment strategy.Nabais, Sergio (Braga)02 Sep 2009Epidemiology & prevention
Influence of equity of access to health care and socio-economic status on the blood pressure profile of vulnerable communities: Results from a national survey of 13,825 adults .Carrington, Melinda (Melbourne)02 Sep 2009Epidemiology & prevention
STEMI outcomes and predictors for cardiac death in older patients: a community-based study.Poerner, Tudor (Jena)02 Sep 2009Epidemiology & prevention

 List of ESC Congress reports on this topic


ArticleAuthorsTopic
Highlights from EuroPRevent Stockholm - new scientific advances Perk, Joep (Oskarshamn, Sweden) Epidemiology & prevention
Genome-wide studies in cardiovascular disease - has the promise been fulfilled? Salonen, Jukka T. (Helsinki, Finland) Epidemiology & prevention
La Dolce Vita: what every cardiologist wants to know about eating, drinking and being active Salonen, Jukka T. (Helsinki, Finland) Epidemiology & prevention
A woman's heart Norekval, Tone Merete (Bergen, Norway)
Deaton,Christi (Manchester, United Kingdom)
Epidemiology & prevention
Recent controversies in diabetics Baumgart, Dietrich (Essen, Germany) Epidemiology & prevention
Treating dyslipidemia. How aggressive should we be? Conraads, Viviane (Edegem, Belgium) Epidemiology & prevention
AAA: Randomised controlled trial of low dose aspirin in the prevention of cardiovascular events and death in subjects with asymptomatic atherosclerosisHot Line IFowkes, Gerry - Patrono, Carlo Epidemiology & prevention
RECORD: Heart failure events assessment in the Rosiglitazone Evaluation for Cardiac Outcomes and Regulation of Glycaemia in DiabetesClinical Trial Update IKomajda, Michel - Dickstein, Kenneth Epidemiology & prevention
RECORD: Effect of rosiglitazone on coronary events in the RECORD studyClinical Trial Update IIMcMurray, John - Charbonnel, Bernard Epidemiology & prevention
JUPITER: Randomized evidence on Rosuvastatin for primary prevention in individuals 70 years of age or olderClinical Trial Update IIGlynn, Robert - Steg, Philippe Gabriel Epidemiology & prevention
Copenhagen City Heart: Nonfasting cholesterol and triglycerides, myocardial infarction, and early deathClinical Trial Update IINordestgaard, Borge - Fuster, Valentin Epidemiology & prevention
Controversies in cardiovascular disease Hobbs, Richard (Birmingham, United Kingdom) Epidemiology & prevention

 List of Webcasted Presentations on this topic


Presentation TitleSpeakerTopicDate
Is elevated resting heart rate an independent predictor of cardiovascular disease? A report from the National FINRISK Study.M T Cooney (Dublin, IE)Epidemiology & prevention30 Aug 2009
Resting heart rate remains a risk factor for CardioVascular (CV) and non-CardioVascular (non-CV) mortality in healthy subjects after adjusting for inflammatory markers. The Copenhagen city heart study.M T Jensen (Copenhagen, DK)Epidemiology & prevention30 Aug 2009
Increased exercise capacity is associated with lower mortality risk in men 70 years and older.P Kokkinos (Washington, US)Epidemiology & prevention30 Aug 2009
Adipokines and coronary heart disease - results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.M Karakas (Ulm, DE)Epidemiology & prevention30 Aug 2009
Respective contribution of carotid intima-media thickness and plaques to incident coronary heart disease in community-dwelling elderly. The three-city study.M Plichart (Paris, FR)Epidemiology & prevention30 Aug 2009
Uric acid: an underestimated cardiovascular risk factor.G Levantesi (Vasto, IT)Epidemiology & prevention30 Aug 2009
Population approach in coronary prevention: the method of choice. Pro.T Jorgensen (Glostrup, DK)Epidemiology & prevention30 Aug 2009
Population approach in coronary prevention: the method of choice: Contra.G De Backer (Ghent, BE)Epidemiology & prevention30 Aug 2009
Population versus high-risk approach in cardiovascular prevention. Conclusion.C M van Duijn (Rotterdam, NL)Epidemiology & prevention30 Aug 2009
Genetic screening of coronary predisposition is coming to clinical practice: Pro.H Schunkert (Lubeck, DE)Epidemiology & prevention30 Aug 2009
Genetic screening of coronary predisposition is coming to clinical practice: Contra.C M van Duijn (Rotterdam, NL)Epidemiology & prevention30 Aug 2009
Genetic screening of coronary predisposition is coming to clinical practice: Pro.H Schunkert (Lubeck, DE)Epidemiology & prevention30 Aug 2009
Genetic screening of coronary predisposition is coming to clinical practice: Contra.C M van Duijn (Rotterdam, NL)Epidemiology & prevention30 Aug 2009
Population versus high-risk approach in cardiovascular prevention: Conclusion.C M van Duijn (Rotterdam, NL)Epidemiology & prevention30 Aug 2009
Randomised controlled trial of low dose aspirin in the prevention of cardiovascular events and death in subjects with asymptomatic atherosclerosis.: Discussant.C Patrono (Rome, IT)Epidemiology & prevention30 Aug 2009
Treating dyslipidemia. How aggressive should we be? Case 1.U Landmesser (Zurich, CH)Epidemiology & prevention30 Aug 2009
Treating dyslipidemia. How aggressive should we be? Case 2.J E Deanfield (London, GB)Epidemiology & prevention30 Aug 2009
What do the Guidelines say?I M Graham (Dublin, IE)Epidemiology & prevention30 Aug 2009
How to cool the burning plaque.V Fuster (New York, US)Epidemiology & prevention31 Aug 2009
Risk factors have no boundaries.D A Wood (London, GB)Epidemiology & prevention31 Aug 2009
Total risk assessment: principles and practice.M-R Taskinen (Helsinki, FI)Epidemiology & prevention31 Aug 2009
Boomerang effect: from low-density lipoprotein to high-density lipoprotein and back.U Landmesser (Zurich, CH)Epidemiology & prevention31 Aug 2009
Modern diabetic management; it's not just glucose.C Berne (Uppsala, SE)Epidemiology & prevention31 Aug 2009
The final piece of the puzzle; comprehensive risk reduction.G De Backer (Ghent, BE)Epidemiology & prevention31 Aug 2009
Causes of cardiovascular disease in Asia and Europe: one and the same?M Woodward (Sydney, AU)Epidemiology & prevention31 Aug 2009
The differences in cardiovascular risk factors and treatment goal achievement between the Asian and the European: results of the Lipid Treatment Assessment Project 2 (L-TAP 2).F-T Chiang (Taipei, TW)Epidemiology & prevention31 Aug 2009
Global alert and prevention of infectious heart diseases.A Matsumori (Kyoto, JP)Epidemiology & prevention31 Aug 2009
Behavioural skills training for health care providers.N Houston-Miller (Palo Alto, US)Epidemiology & prevention31 Aug 2009
Motivational interviewing - is it effective in cardiovascular prevention?PM Davidson (Sydney, AU)Epidemiology & prevention31 Aug 2009
Behavioural change - it's all in the family.C S Jennings (London, GB)Epidemiology & prevention31 Aug 2009
Can we change society?J Tuomilehto (Helsinki, FI)Epidemiology & prevention31 Aug 2009
Olive oil, berries and chocolate.M De Lorgeril (La Tronche, FR)Epidemiology & prevention31 Aug 2009
Hop, skip or jump.P Doherty (York, GB)Epidemiology & prevention31 Aug 2009
I did it my way.S Sharma (London, GB)Epidemiology & prevention31 Aug 2009
Randomized evidence on Rosuvastatin for primary prevention in individuals 70 years of age or older. JUPITER.R Glynn (Boston, US)Epidemiology & prevention31 Aug 2009
JUPITER: Discussant.P G Steg (Paris Cedex 18, FR)Epidemiology & prevention31 Aug 2009
Copenhagen City Heart. Discussant.V Fuster (New York, US)Epidemiology & prevention31 Aug 2009
Barriers to implementation.I M Graham (Dublin, IE)Epidemiology & prevention31 Aug 2009
Political alliances and engagement - prerequisites for success.L Ryden (Stockholm, SE), S Logstrup (Brussels, BE)Epidemiology & prevention31 Aug 2009
Factors influencing physician and patient behaviour.C Albus (Cologne (Koeln), DE)Epidemiology & prevention31 Aug 2009
A national plan for cardiovascular disease prevention.C Erol (Ankara, TR)Epidemiology & prevention31 Aug 2009
The 'Call for Action': putting strategy into practice.G De Backer (Ghent, BE)Epidemiology & prevention31 Aug 2009
Acquired immune deficiency syndrome in the heart of Africa.B M Mayosi (Cape Town, ZA)Epidemiology & prevention01 Sep 2009
Hypertension: meeting the need in Africa.D Lemogoum (Brussels, BE)Epidemiology & prevention01 Sep 2009
Advances in the medical and surgical treatment of endomyocardial fibrosis.A O Mocumbi (Maputo, MZ)Epidemiology & prevention01 Sep 2009
The role of Pan African Society of Cardiology.A G B Amoah (Accra., GH)Epidemiology & prevention01 Sep 2009
Risk stratification and coronary heart disease.S Silber (Muenchen, DE)Epidemiology & prevention01 Sep 2009
Predicting cardiovascular disease: does C-reactive protein add anything?T A Pearson (Rochester, US)Epidemiology & prevention01 Sep 2009
What's the quality of cardiovascular care in European primary care?S Ludt (Heidelberg, DE)Epidemiology & prevention01 Sep 2009
Exercise and mitochondrial biogenesis.R Ventura-Clapier (Chatenay-Malabry, FR)Epidemiology & prevention01 Sep 2009
Differential impact of training regime on cardiac muscle biology.O J Kemi (Glasgow, GB)Epidemiology & prevention01 Sep 2009
Improving outcomes with exercise: fitness or risk factors?L E M Vanhees (Leuven, BE)Epidemiology & prevention01 Sep 2009
Optimising exercise training for global cardiovascular health.R Hambrecht (Bremen, DE)Epidemiology & prevention01 Sep 2009
Mechanisms of arterial ageing.J R Cockcroft (Cardiff, GB)Epidemiology & prevention01 Sep 2009
Morphological and functional changes of the aged arteries.J Lekakis (Haidari, Athens, GR)Epidemiology & prevention01 Sep 2009
Differences between arterial ageing and atherosclerosis.L Tokgozoglu (Ankara, TR)Epidemiology & prevention01 Sep 2009
Prevention: Highlight SessionJ Perk (Oskarshamn, SE)Epidemiology & prevention02 Sep 2009
ASCOT: Anglo-Scandinavian Cardiac Outcomes Trial: 10 year follow-up of the Lipid_lowering ArmlP S.Sever ( London-United Kingdom)Primary cardiovascular prevention: interventions and outcomes28 Aug 2011
Discussant - ASCOT: Anglo-Scandinavian Cardiac Outcomes Trial: 10 year follow-up of the Lipid_lowering ArmlG.De Backer ( St Martens Latem-Belgium)Primary cardiovascular prevention: interventions and outcomes28 Aug 2011
EUROACTION preventive cardiology programme plus intensive smoking cessation with VareniclineD A.Wood ( London-United Kingdom)Primary cardiovascular prevention: interventions and outcomes28 Aug 2011
EUROASPIRE III: modelling the clinical and cost-effectiveness of optimizing cardiovascular prevention in patients with established coronary heart disease in EuropeL.Annemans ( Gent-Belgium)Secondary cardiovascular prevention: interventions and outcomes28 Aug 2011
PURE: The prevention gaps in 17 low, middle and high income countries involving over 150,000 peopleS.Yusuf ( Hamilton-Canada)Secondary cardiovascular prevention: interventions and outcomes28 Aug 2011
Discussant - PURE: The prevention gaps in 17 low, middle and high income countries involving over 150,000 peopleA P.Maggioni ( Florence-Italy)Secondary cardiovascular prevention: interventions and outcomes28 Aug 2011
HCS: Prospective evaluation of post-prandial triglycerides and cardiovascular events in patients with coronary artery diseaseU.Laufs ( Homburg-Germany)Secondary cardiovascular prevention: interventions and outcomes28 Aug 2011
Discussant - HCS: Prospective evaluation of post-prandial triglycerides and cardiovascular events in patients with coronary artery diseaseP J.Barter ( Sydney-Australia)Secondary cardiovascular prevention: interventions and outcomes28 Aug 2011
dal-VESSEL: Efficacy and safety of dalcetrapib in patients with or at risk of coronary heart disease - the dal-VESSEL trialT F.Luescher ( Zurich-Switzerland)Primary cardiovascular prevention: interventions and outcomes28 Aug 2011
Discussant - dal-VESSEL: Efficacy and safety of dalcetrapib in patients with or at risk of coronary heart disease - the dal-VESSEL trialK A A.Fox ( Edinburgh-United Kingdom)Primary cardiovascular prevention: interventions and outcomes28 Aug 2011
Effectiveness in the RESPONSE trial.R J G.Peters ( Amsterdam-Netherlands)Secondary cardiovascular prevention: interventions and outcomes29 Aug 2011
Feasibility in the EUROACTION study.C S.Jennings ( London-United Kingdom)Secondary cardiovascular prevention: interventions and outcomes29 Aug 2011
Should we only focus on nurse-led programmes?J.Perk ( Kalmar-Sweden)Secondary cardiovascular prevention: interventions and outcomes29 Aug 2011
Do we know how to do it?N.Houston-Miller ( Stanford-United States of America)Secondary cardiovascular prevention: interventions and outcomes29 Aug 2011
Smoking relapse and mortality after acute coronary syndromesF.Colivicchi ( Rome-Italy)Secondary cardiovascular prevention: interventions and outcomes29 Aug 2011
Persistent smoking in high-risk patients - the reality in clinical practice and how to improve.K.Kotseva ( London-United Kingdom)Primary cardiovascular prevention: interventions and outcomes29 Aug 2011
Strategies for smoking cessation - evidence from trials.D A.Wood ( London-United Kingdom)Primary cardiovascular prevention: interventions and outcomes29 Aug 2011
Cardiovascular prevention; a global problem.U.Keil ( Muenster-Germany)Primary cardiovascular prevention: interventions and outcomes30 Aug 2011
Polypill for primary prevention.S.Yusuf ( Hamilton-Canada)Primary cardiovascular prevention: interventions and outcomes30 Aug 2011
Polypill for secondary prevention.V.Fuster ( New York-United States of America)Primary cardiovascular prevention: interventions and outcomes30 Aug 2011
Alternatives to polypills.AJ.Taylor ( Washington-United States of America)Primary cardiovascular prevention: interventions and outcomes30 Aug 2011